Bristol, Merck, AbbVie face House committee probe over China trials
Seeking Alpha ·
The House Select Committee on China has opened investigations into Bristol Myers Squibb ( BMY ), Merck ( MRK ), Pfizer ( PFE ), and AbbVie ( ABBV ) over the companies' clinical trials at Chinese military sites or hospitals. In a letter to Bristol CEO Chris Boerner,
DYAX Investor Sentiment
Bullish (Long) 51% · Bearish (Short) 49%
414 participants
Related News
- Constellation Brands Non-GAAP EPS of $3.43 beats by $0.23, revenue of $2.43B beats by $40M
- Neurogene launches public stock offering
- AbbVie shares fell after six-session winning streak
- SA analyst says end-of-quarter positioning may be distorting market moves
- SpaceX faces tough regulatory road to wireless networks, BNP Paribas says
- Merck declines after six-day rally